# RECARBRIO
> **NDA212819** · New Drug Application · Sponsor: MSD MERCK CO · Approved 2019-07-16
## Drug
- **FDA Application Number:** NDA212819
- **Application type:** New Drug Application
- **Brand name:** RECARBRIO
- **Generic name:** IMIPENEM ANHYDROUS, CILASTATIN, AND RELEBACTAM ANHYDROUS
- **Active ingredients:** CILASTATIN SODIUM; IMIPENEM; RELEBACTAM
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** MSD MERCK CO
- **Manufacturer:** Merck Sharp & Dohme LLC
- **First approval:** 2019-07-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212819)
---
*AI Analytics · CC0 1.0*